HEATHER MCCLURE: Open Payments
NPI 1871968271 · RICHMOND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,004 in 119 payments from 19 companies in 2025. Trend: 2023 $1,087 · 2024 $1,157 · 2025 $2,004
Food & beverage: $2,004
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 21 | $353 |
| Alkermes, Inc. | 16 | $256 |
| ABBVIE INC. | 16 | $217 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $183 |
| Axsome Therapeutics, Inc. | 6 | $169 |
| Otsuka America Pharmaceutical, Inc. | 8 | $155 |
| AstraZeneca Pharmaceuticals LP | 5 | $149 |
| GlaxoSmithKline, LLC. | 4 | $91 |
| Teva Pharmaceuticals USA, Inc. | 5 | $89 |
| Indivior Inc. | 5 | $89 |
Products named: FANAPT, CAPLYTA, Auvelity, LYBALVI, VRAYLAR, REXULTI, ARISTADA, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
